Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

44%

4 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4

4(57.1%)

N/A

2(28.6%)

Phase 2

1(14.3%)

7Total

Phase 4(4)

N/A(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT01603316Phase 2Active Not Recruiting

Food: A Three-Arm Study Examining Food Insecurity Interventions

Role: collaborator

NCT03789968Completed

The Incidence and Severity of Drug Interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experienced Patients

Role: collaborator

NCT04468048Withdrawn

Music Utilization in Sedation and Induction in Colonoscopy

Role: lead

NCT03137498Phase 4Unknown

Lidocaine vs Ketorolac for Management of Renal Colic in the Emergency Department

Role: lead

NCT03221569Phase 4Unknown

Ketamine v. Ketorolac for Management of Generalized Tension Type Headache

Role: lead

NCT02306759Phase 4Completed

Ketamine For Acute Treatment of Pain in Emergency Department

Role: lead

NCT03224039Phase 4Unknown

Intranasal Sufentanil Versus Intravenous Morphine for the Management of Acute Pain

Role: lead

NCT01616940Not ApplicableCompleted

Minority AIDS Initiative Retention and Re-Engagement Project

Role: collaborator

NCT02269033Not ApplicableCompleted

Redes II National Patient Navigator Intervention Study

Role: collaborator

All 9 trials loaded